公开(公告)号：US07202343B2

公开(公告)日：2007-04-10

申请号：US10644277

申请日：2003-08-19

申请人： Jean M. Gudas ,  Mary Haak-Frendscho ,  Orit Foord ,  Meina L. Liang ,  Kiran Ahluwalia ,  Sunil Bhakta

发明人： Jean M. Gudas ,  Mary Haak-Frendscho ,  Orit Foord ,  Meina L. Liang ,  Kiran Ahluwalia ,  Sunil Bhakta

IPC分类号： C07K16/00

CPC分类号： C07K16/24 ,  A61K2039/505 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/56 ,  C07K2317/565

摘要： Embodiments of the invention described herein relate to antibodies directed to the antigen monocyte chemo-attractant protein-1 (MCP-1) and uses of such antibodies. In particular, in accordance with some embodiments, there are provided fully human monoclonal antibodies directed to the antigen MCP-1. Nucelotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.

公开(公告)号：US20050013809A1

公开(公告)日：2005-01-20

申请号：US10725962

申请日：2003-12-02

申请人： Samuel Owens ,  Frank Carroll ,  Philip Abraham ,  Melinda Gunnell ,  Mary Haak-Frendscho ,  Xiao Feng

发明人： Samuel Owens ,  Frank Carroll ,  Philip Abraham ,  Melinda Gunnell ,  Mary Haak-Frendscho ,  Xiao Feng

IPC分类号： C07K16/44 ,  A61K39/395 ,  C07K16/18 ,  C12N5/06

CPC分类号： C07K16/44 ,  A61K2039/505 ,  C07K2317/21 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/567

摘要： The present invention is related to antibodies directed to various drugs of abuse and uses of such antibodies. In preferred embodiments, the drugs of abuse are amphetamine, methamphetamine, or phencyclidine (PCP). In particular, in accordance with the present invention, there are provided fully man monoclonal antibodies directed to drugs of abuse. Nucelotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR3 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.

摘要翻译： 本发明涉及针对各种滥用药物的抗体和使用此类抗体的抗体。 在优选的实施方案中，滥用药物是苯丙胺，甲基苯丙胺或苯环利定（PCP）。 特别地，根据本发明，提供了针对滥用药物的完全人单克隆抗体。 编码Nuclotide序列和包含重链和轻链免疫球蛋白分子的氨基酸序列，特别是对应于跨越框架区和/或互补决定区（CDR）的连续重链和轻链序列的序列，特别是从FR1至FR3或CDR1至CDR3 ，提供。 还提供了表达这种免疫球蛋白分子和单克隆抗体的杂交瘤或其它细胞系。

公开(公告)号：US20070166308A1

公开(公告)日：2007-07-19

申请号：US11484247

申请日：2006-07-10

申请人： Nicholas Pullen ,  Elizabeth Molloy ,  Sirid-Aimee Kellermann ,  Larry Green ,  Mary Haak-Frendscho

发明人： Nicholas Pullen ,  Elizabeth Molloy ,  Sirid-Aimee Kellermann ,  Larry Green ,  Mary Haak-Frendscho

IPC分类号： A61K39/395 ,  C12N5/06 ,  C07K16/28

CPC分类号： C07K16/2803 ,  A61K2039/505 ,  C07K14/70503 ,  C07K2317/21 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/76 ,  C07K2317/92 ,  G01N33/56972 ,  G01N33/6854 ,  G01N2333/70503 ,  G01N2333/70546

摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to MAdCAM, preferably human MAdCAM and that function to inhibit MAdCAM. The invention also relates to human anti-MAdCAM antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-MAdCAM antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-MAdCAM antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-MAdCAM antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the invention.

摘要翻译： 本发明涉及特异性结合MAdCAM，优选人MAdCAM的人抗体及其抗原结合部分的抗体，其功能是抑制MAdCAM。 本发明还涉及人抗MAdCAM抗体及其抗原结合部分。 本发明还涉及嵌合，双特异性，衍生的单链抗体或融合蛋白的部分的抗体。 本发明还涉及衍生自人抗MAdCAM抗体的分离的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗MAdCAM抗体的方法，包含这些抗体的组合物和使用抗体和组合物进行诊断和治疗的方法。 本发明还提供使用编码包含人抗MAdCAM抗体的重和/或轻免疫球蛋白分子的核酸分子的基因治疗方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。

公开(公告)号：US20050232917A1

公开(公告)日：2005-10-20

申请号：US11031485

申请日：2005-01-07

申请人： Nicholas Pullen ,  Elizabeth Molloy ,  Sirid-Aimee Kellermann ,  Larry Green ,  Mary Haak-Frendscho

发明人： Nicholas Pullen ,  Elizabeth Molloy ,  Sirid-Aimee Kellermann ,  Larry Green ,  Mary Haak-Frendscho

IPC分类号： A61K39/395 ,  C07K16/28 ,  C12N5/06

CPC分类号： C07K16/2803 ,  A61K2039/505 ,  C07K14/70503 ,  C07K2317/21 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/76 ,  C07K2317/92 ,  G01N33/56972 ,  G01N33/6854 ,  G01N2333/70503 ,  G01N2333/70546

摘要： The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to MAdCAM, preferably human MAdCAM and that function to inhibit MAdCAM. The invention also relates to human anti-MAdCAM antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-MAdCAM antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-MAdCAM antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-MAdCAM antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the invention.

摘要翻译： 本发明涉及特异性结合MAdCAM，优选人MAdCAM的人抗体及其抗原结合部分的抗体，其功能是抑制MAdCAM。 本发明还涉及人抗MAdCAM抗体及其抗原结合部分。 本发明还涉及嵌合，双特异性，衍生的单链抗体或融合蛋白的部分的抗体。 本发明还涉及衍生自人抗MAdCAM抗体的分离的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗MAdCAM抗体的方法，包含这些抗体的组合物和使用抗体和组合物进行诊断和治疗的方法。 本发明还提供使用编码包含人抗MAdCAM抗体的重和/或轻免疫球蛋白分子的核酸分子的基因治疗方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。

公开(公告)号：US08377442B2

公开(公告)日：2013-02-19

申请号：US13109680

申请日：2011-05-17

申请人： Linda Masat ,  Mary Haak-Frendscho ,  Gang Chen ,  Arnold Horwitz ,  Marina Roell

发明人： Linda Masat ,  Mary Haak-Frendscho ,  Gang Chen ,  Arnold Horwitz ,  Marina Roell

IPC分类号： A61K39/395

CPC分类号： C07K16/244 ,  A61K2039/505 ,  C07K16/245 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/76 ,  C07K2317/92 ,  Y10S514/885

摘要： An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

摘要翻译： IL-1和bgr 结合抗体或IL-1和bgr; 结合片段，其包含SEQ ID NO：2的氨基酸序列：2，以及相关的核酸，载体，细胞，和组合物，以及使用其治疗或预防疾病的方法，以及制备具有亲和性的方法成熟IL -1＆bgr 结合多肽。 IL-1和bgr 结合抗体或IL-1和bgr; 提供其结合片段，其具有期望的亲和力和效力。

公开(公告)号：US08188249B2

公开(公告)日：2012-05-29

申请号：US12748602

申请日：2010-03-29

申请人： Vahe Bedian ,  Madhav Narasimha Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimee Kellermann ,  Joseph Edwin Low ,  James Leslie Mobley

发明人： Vahe Bedian ,  Madhav Narasimha Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimee Kellermann ,  Joseph Edwin Low ,  James Leslie Mobley

IPC分类号： C07H21/04 ,  C12N15/00 ,  C12N5/07 ,  C12N5/16

CPC分类号： C07K16/243 ,  A61K38/193 ,  A61K39/395 ,  A61K2039/505 ,  C07K16/24 ,  C07K2317/14 ,  C07K2317/21 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92 ,  G06Q30/02 ,  G06Q30/0601 ,  G06Q40/04 ,  G06Q50/12 ,  Y02A50/412

摘要： The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function to inhibit a M-CSF. The invention also relates to human anti-M-CSF antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-M-CSF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-M-CSF antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-M-CSF antibodies. The invention also relates to transgenic animals and transgenic plants comprising nucleic acid molecules of the present invention.

摘要翻译： 本发明涉及特异性结合M-CSF，优选人M-CSF的抗体及其抗原结合部分，其功能是抑制M-CSF。 本发明还涉及人抗M-CSF抗体及其抗原结合部分。 本发明还涉及嵌合，双特异性，衍生的单链抗体或融合蛋白的部分的抗体。 本发明还涉及衍生自人抗M-CSF抗体的分离的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗M-CSF抗体的方法，包含这些抗体的组合物和使用该抗体和组合物进行诊断和治疗的方法。 本发明还提供使用编码包含人抗M-CSF抗体的重和/或轻免疫球蛋白分子的核酸分子的基因治疗方法。 本发明还涉及包含本发明的核酸分子的转基因动物和转基因植物。

公开(公告)号：US07988968B2

公开(公告)日：2011-08-02

申请号：US12464323

申请日：2009-05-12

申请人： Linda Masat ,  Mary Haak-Frendscho ,  Arnold H. Horwitz ,  Gang Chen ,  Marina Roell

发明人： Linda Masat ,  Mary Haak-Frendscho ,  Arnold H. Horwitz ,  Gang Chen ,  Marina Roell

IPC分类号： A61K39/395

CPC分类号： C07K16/244 ,  A61K2039/505 ,  C07K16/245 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/76 ,  C07K2317/92 ,  Y10S514/885

摘要： An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

摘要翻译： IL-1和bgr 结合抗体或IL-1和bgr; 包含SEQ ID NO：2的氨基酸序列的结合片段，以及相关的核酸，载体，细胞和组合物，以及其用于治疗或预防疾病的方法，以及制备亲和力成熟的IL的方法 -1＆bgr 结合多肽。 IL-1和bgr 结合抗体或IL-1和bgr; 提供其结合片段，其具有期望的亲和力和效力。

公开(公告)号：US07829094B2

公开(公告)日：2010-11-09

申请号：US12464061

申请日：2009-05-11

申请人： Linda Masat ,  Mary Haak-Frendscho ,  Arnold H. Horwitz ,  Gang Chen ,  Marina Roell

发明人： Linda Masat ,  Mary Haak-Frendscho ,  Arnold H. Horwitz ,  Gang Chen ,  Marina Roell

IPC分类号： A61K39/395

CPC分类号： C07K16/244 ,  A61K2039/505 ,  C07K16/245 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/76 ,  C07K2317/92 ,  Y10S514/885

摘要： Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO: 15 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

摘要翻译： 治疗或预防哺乳动物中IL-1相关疾病或病症的方法，包括给予有效量的IL-1和bgr; 结合抗体或IL-1和bgr; 其结合片段。 IL-1和bgr 结合抗体或IL-1和bgr; 提供了包含SEQ ID NO：15和SEQ ID NO：11的氨基酸序列以及相关核酸，载体，细胞和组合物的结合片段，以及制备亲和力成熟的IL-1和bgr的方法。 结合多肽。 IL-1和bgr 结合抗体或IL-1和bgr; 提供其结合片段，其具有期望的亲和力和效力。

公开(公告)号：US20100247545A1

公开(公告)日：2010-09-30

申请号：US12748602

申请日：2010-03-29

申请人： Vahe Bedian ,  Madhav Narasimha Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimée Kellermann ,  Joseph Edwin Low ,  James Leslie Mobley

发明人： Vahe Bedian ,  Madhav Narasimha Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimée Kellermann ,  Joseph Edwin Low ,  James Leslie Mobley

IPC分类号： A61K39/395 ,  C07K16/24 ,  C07H21/04 ,  C12N15/63 ,  C12P21/02 ,  A61P35/00 ,  C12N5/18 ,  C12N5/10

CPC分类号： C07K16/243 ,  A61K38/193 ,  A61K39/395 ,  A61K2039/505 ,  C07K16/24 ,  C07K2317/14 ,  C07K2317/21 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92 ,  G06Q30/02 ,  G06Q30/0601 ,  G06Q40/04 ,  G06Q50/12 ,  Y02A50/412

摘要： The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function to inhibit a M-CSF. The invention also relates to human anti-M-CSF antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-M-CSF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-M-CSF antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-M-CSF antibodies. The invention also relates to transgenic animals and transgenic plants comprising nucleic acid molecules of the present invention.

摘要翻译： 本发明涉及特异性结合M-CSF，优选人M-CSF的抗体及其抗原结合部分，其功能是抑制M-CSF。 本发明还涉及人抗M-CSF抗体及其抗原结合部分。 本发明还涉及嵌合，双特异性，衍生的单链抗体或融合蛋白的部分的抗体。 本发明还涉及衍生自人抗M-CSF抗体的分离的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗M-CSF抗体的方法，包含这些抗体的组合物和使用该抗体和组合物进行诊断和治疗的方法。 本发明还提供使用编码包含人抗M-CSF抗体的重和/或轻免疫球蛋白分子的核酸分子的基因治疗方法。 本发明还涉及包含本发明的核酸分子的转基因动物和转基因植物。

公开(公告)号：US20060153850A1

公开(公告)日：2006-07-13

申请号：US11375221

申请日：2006-03-13

申请人： Vahe Bedian ,  Madhav Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimee Kellermann ,  Joseph Low ,  James Mobley

发明人： Vahe Bedian ,  Madhav Devalaraja ,  Ian Foltz ,  Mary Haak-Frendscho ,  Sirid-Aimee Kellermann ,  Joseph Low ,  James Mobley

IPC分类号： A61K39/395 ,  C07K16/24

CPC分类号： C07K16/243 ,  A61K38/193 ,  A61K39/395 ,  A61K2039/505 ,  C07K16/24 ,  C07K2317/14 ,  C07K2317/21 ,  C07K2317/56 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92 ,  G06Q30/02 ,  G06Q30/0601 ,  G06Q40/04 ,  G06Q50/12 ,  Y02A50/412

摘要： The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function to inhibit a M-CSF. The invention also relates to human anti-M-CSF antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-M-CSF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-M-CSF antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-M-CSF antibodies. The invention also relates to transgenic animals and transgenic plants comprising nucleic acid molecules of the present invention.